LCT In The News

12 January 2022

Why putting animal organs inside people could be the future of medicine

Surgeon Christiaan Barnard performed the world’s first successful human heart transplant in 1967. Now doctors have performed the first successful transplantation of a pig’s heart into a human. Experts suggest genetically modified pigs could even produce blood suitable for human transfusion, or dopamine for Parkinson’s sufferers. 

31 August 2021

Parkinson’s disease market sales to reach $11.5 billion in 2029

The Parkinson’s disease (PD) market is expected to almost triple in sales in the seven major markets (7MM) – US, France, Germany, Spain, Italy, UK and Japan – by 2029, rising from $4 billion in 2021 at a 12.6 percent compound annual growth rate (CAGR), GlobalData has reported. The company noted that this growth is largely driven by the lau...

14 July 2020

Sir Richard Faull on RNZ National

On Saturday Morning on RNZ National, LCT Scientific Advisor Sir Richard Faull and businessman Bernie Crosby talk to Kim Hill about the work of the University of Auckland Centre for Brain Research and finding a cure for Parkinson's disease.

2 June 2020

Bob Elliott knighted

Dr Robert Elliott has been knighted in this year's Queen's Birthday Honours for his contributions to medical research. 

A doctor who improved the lives of thousands of people through his research, Dr Robert Elliott, 86, made a medical breakthrough in the 1970s that extended the lifespan of people with cystic fibrosis by decades.

14 June 2019

Pig brain cells implanted into brains of people with Parkinson’s

Would you have pig cells implanted in your brain? Some people with Parkinson’s disease have, in the hope it will stop their disease progressing. The approach is still in the early stages of testing, but initial results from four people look promising, with all showing some improvement 18 months after surgery. Living Cell Technologies, based in...

14 May 2018

LCT expects crucial Parkinson’s clinical trial results in early 2017

Australasian biotech company Living Cell Technologies says it will know the outcome of a make-or-break clinical trial on its regenerative cell therapy for Parkinson's disease in the first quarter of next year. If the trial succeeds, Living Cell's lead product NTCELL will be the world's first disease-modifying treatment for Parkinson's as existin...